BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 25179242)

  • 21. Early prediction of phenotypic severity in Citrullinemia Type 1.
    Zielonka M; Kölker S; Gleich F; Stützenberger N; Nagamani SCS; Gropman AL; Hoffmann GF; Garbade SF; Posset R;
    Ann Clin Transl Neurol; 2019 Sep; 6(9):1858-1871. PubMed ID: 31469252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Citrullinemia type I: molecular screening of the ASS1 gene by exonic sequencing and targeted mutation analysis.
    Marquis-Nicholson R; Glamuzina E; Prosser D; Wilson C; Love DR
    Genet Mol Res; 2010 Aug; 9(3):1483-9. PubMed ID: 20690080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of late-onset citrullinemia 1 in a Korean patient: confirmation by argininosuccinate synthetase gene mutation analysis.
    Kim IS; Ki CS; Kim JW; Lee M; Jin DK; Lee SY
    J Biochem Mol Biol; 2006 Jul; 39(4):400-5. PubMed ID: 16889683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of citrullinemia type I variants by in vitro expression studies.
    Berning C; Bieger I; Pauli S; Vermeulen T; Vogl T; Rummel T; Höhne W; Koch HG; Rolinski B; Gempel K; Häberle J
    Hum Mutat; 2008 Oct; 29(10):1222-7. PubMed ID: 18473344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Additional mutations in argininosuccinate synthetase causing citrullinemia.
    Kobayashi K; Rosenbloom C; Beaudet AL; O'Brien WE
    Mol Biol Med; 1991 Feb; 8(1):95-100. PubMed ID: 1943692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutations in argininosuccinate synthetase mRNA of Japanese patients, causing classical citrullinemia.
    Kobayashi K; Shaheen N; Terazono H; Saheki T
    Am J Hum Genet; 1994 Dec; 55(6):1103-12. PubMed ID: 7977368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of ASS1 gene in ten unrelated middle eastern families with citrullinemia type 1 identifies rare and novel variants.
    Daou M; Souaid M; Yammine T; Khneisser I; Mansour H; Salem N; Nemr A; Awwad J; Moukarzel A; Farra C
    Mol Genet Genomic Med; 2023 Feb; 11(2):e2058. PubMed ID: 36680390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early cirrhosis in a patient with type I citrullinaemia (CTLN1).
    Güçer S; Aşan E; Atilla P; Tokatli A; Cağlar M
    J Inherit Metab Dis; 2004; 27(4):541-2. PubMed ID: 15334737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterogeneity of mutations in argininosuccinate synthetase causing human citrullinemia.
    Kobayashi K; Jackson MJ; Tick DB; O'Brien WE; Beaudet AL
    J Biol Chem; 1990 Jul; 265(19):11361-7. PubMed ID: 2358466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Citrullinaemia type I: a common mutation in the Pacific Island population.
    Glamuzina E; Marquis-Nicholson R; Knoll D; Love DR; Wilson C
    J Paediatr Child Health; 2011 May; 47(5):262-5. PubMed ID: 21244552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ASS1 deficiency is associated with impaired neuronal differentiation in zebrafish larvae.
    Seidl MJ; Scharre S; Posset R; Druck AC; Epp F; Okun JG; Dimitrov B; Hoffmann GF; Kölker S; Zielonka M
    Mol Genet Metab; 2024 Jan; 141(1):108097. PubMed ID: 38113552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pregnancy in a healthy woman with untreated citrullinemia.
    Potter MA; Zeesman S; Brennan B; Kobayashi K; Gao HZ; Tabata A; Saheki T; Whelan DT
    Am J Med Genet A; 2004 Aug; 129A(1):77-82. PubMed ID: 15266621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Mutational analysis of ASS1, ASL and SLC25A13 genes in six Chinese patients with citrullinemia].
    Lin Y; Yu K; Li L; Zheng Z; Lin W; Fu Q
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Oct; 34(5):676-679. PubMed ID: 28981931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extracellular vesicles from human liver stem cells restore argininosuccinate synthase deficiency.
    Herrera Sanchez MB; Previdi S; Bruno S; Fonsato V; Deregibus MC; Kholia S; Petrillo S; Tolosano E; Critelli R; Spada M; Romagnoli R; Salizzoni M; Tetta C; Camussi G
    Stem Cell Res Ther; 2017 Jul; 8(1):176. PubMed ID: 28750687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenotype and genotype heterogeneity in Mediterranean citrullinemia.
    Vilaseca MA; Kobayashi K; Briones P; Lambruschini N; Campistol J; Tabata A; Alomar A; Rodès M; Lluch M; Saheki T
    Mol Genet Metab; 2001 Nov; 74(3):396-8. PubMed ID: 11708871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutations and DNA diagnoses of classical citrullinemia.
    Kakinoki H; Kobayashi K; Terazono H; Nagata Y; Saheki T
    Hum Mutat; 1997; 9(3):250-9. PubMed ID: 9090528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene Therapy in Combination with Nitrogen Scavenger Pretreatment Corrects Biochemical and Behavioral Abnormalities of Infant Citrullinemia Type 1 Mice.
    Bazo A; Lantero A; Mauleón I; Neri L; Poms M; Häberle J; Ricobaraza A; Bénichou B; Combal JP; Gonzalez-Aseguinolaza G; Aldabe R
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel human pathological mutations. Gene symbol: ASS1. Disease: Citrullinaemia.
    Dimmock D; Trapane P; Feigenbaum A; Keegan CE; Cederbaum S; Gibson J; Gambello MJ; Vaux K; Ward P; Rice GM; Wolff JA; O'Brien WE; Fang P
    Hum Genet; 2009 Aug; 126(2):342. PubMed ID: 19694026
    [No Abstract]   [Full Text] [Related]  

  • 39. Novel human pathological mutations. Gene symbol: ASS1. Disease: Citrullinaemia.
    Dimmock D; Trapane P; Feigenbaum A; Keegan CE; Cederbaum S; Gibson J; Gambello MJ; Vaux K; Ward P; Rice GM; Wolff JA; O'Brien WE; Fang P
    Hum Genet; 2009 Aug; 126(2):341. PubMed ID: 19694025
    [No Abstract]   [Full Text] [Related]  

  • 40. Mutation analysis of Korean patients with citrullinemia.
    Hong KM; Shin CH; Choi YB; Song WK; Lee SD; Rhee KI; Jang P; Pak GS; Kim JK; Paik MK; Hahn SH
    Mol Cells; 2000 Aug; 10(4):465-8. PubMed ID: 10987146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.